Pregnancy outcome in afibrinogenemia: Are we giving enough fibrinogen concentrate? A case series

by Joline L. Saes, Britta A. P. Laros‐van Gorkom, Michiel Coppens, Saskia E. M. Schols
Published 2020-02-01

Apixaban-Calibrated Anti-FXa Activity in Relation to Outcome Events and Clinical Characteristics in Patients with Atrial Fibrillation: Results from the AVERROES Trial

by Vinai C. Bhagirath, John W. Eikelboom, Jack Hirsh, Michiel Coppens, Jeffrey Ginsberg, Thomas Vanassche, Fei Yuan, Noel Chan, Salim Yusuf, Stuart J. Connolly
Published 2017-07-01

Effects of a hospital-wide introduction of a massive transfusion protocol on blood product ratio and blood product waste

by Kirsten Balvers, Michiel Coppens, Susan van Dieren, Ingeborg H.M. van Rooyen-Schreurs, Henriëtte J Klinkspoor, Sacha S Zeerleder, Holger M Baumann, J Carel Goslings, Nicole P Juffermans
Published 2015-01-01

Congenital platelet disorders and health status–related quality of life

by Maaike W. Blaauwgeers, Marieke J. H. A. Kruip, Erik A. M. Beckers, Michiel Coppens, Jeroen Eikenboom, Karin P. M. vanGalen, Rienk Y. J. Tamminga, Rolf T. Urbanus, Roger E. G. Schutgens, the TiN study group
Published 2020-01-01

Emergencies on direct oral anticoagulants: Management, outcomes, and laboratory effects of prothrombin complex concentrate

by Roisin Bavalia, Rahat Abdoellakhan, Herm Jan M. Brinkman, Marjolein P. A. Brekelmans, Eva N. Hamulyák, Marleen Zuurveld, Barbara A. Hutten, Peter E. Westerweel, Renske H. Olie, Hugo ten Cate, Marieke Kruip, Saskia Middeldorp, Karina Meijer, Michiel Coppens
Published 2020-05-01

Correction to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) s...

by Alexander T. Cohen, Cihan Ay, Philippe Hainaut, Hervé Décousus, Ulrich Hoffmann, Sean Gaine, Michiel Coppens, Pedro Marques da Silva, David Jimenez, Beatrice Amann-Vesti, Bernd Brüggenjürgen, Pierre Levy, Julio Lopez Bastida, Eric Vicaut, Petra Laeis, Eva-Maria Fronk, Wolfgang Zierhut, Thomas Malzer, Peter Bramlage, Giancarlo Agnelli, on behalf of the ETNA-VTE-Europe investigators
Published 2018-05-01

Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study

by Alexander T. Cohen, Cihan Ay, Philippe Hainaut, Hervé Décousus, Ulrich Hoffmann, Sean Gaine, Michiel Coppens, Pedro Marques da Silva, David Jiménez, Beatrice Amann-Vesti, Bernd Brüggenjürgen, Pierre Levy, Julio Lopez Bastida, Eric Vicaut, Petra Laeis, Eva-Maria Fronk, Wolfgang Zierhut, Thomas Malzer, Peter Bramlage, Giancarlo Agnelli, on behalf of the ETNA-VTE-Europe investigators
Published 2018-05-01

CAVA (Ultrasound‐Accelerated Catheter‐Directed Thrombolysis on Preventing Post‐Thrombotic Syndrome) Trial: Long‐Term Follow‐Up Results

by Pascale Notten, André A. E. A. de Smet, Lidwine W. Tick, Marlène H. W. van de Poel, Otmar R. M. Wikkeling, Louis‐Jean Vleming, Ad Koster, Kon‐Siong G. Jie, Esther M. G. Jacobs, Harm P. Ebben, Michiel Coppens, Hugo ten Cate, Cees H. A. Wittens, Arina J. ten Cate‐Hoek
Published 2021-06-01

Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin

by Roisin Bavalia, Ingrid M. Bistervels, Wim G. Boersma, Isabelle Quere, Dominique Brisot, Nicolas Falvo, Dominique Stephan, Francis Couturaud, Sebastian Schellong, Jan Beyer‐Westendorf, Karine Montaclair, Waleed Ghanima, Marije ten Wolde, Michiel Coppens, Emile Ferrari, Olivier Sanchez, Patrick Carroll, Pierre‐Marie Roy, Susan R. Kahn, Karina Meijer, Simone Birocchi, Michael J. Kovacs, Amanda Hugman, Hugo ten Cate, Hilde Wik, Gilles Pernod, Marie‐Antoinette Sevestre‐Pietri, Michael A. Grosso, Minggao Shi, Yong Lin, Barbara A. Hutten, Peter Verhamme, Saskia Middeldorp, the Hokusai post‐PE study investigators
Published 2021-07-01